Gland Pharma Limited (GLAND) — Strategic Asset Allocation Index
Gland Pharma Limited (GLAND) has a Strategic Asset Allocation Index of 21.9% as of September 2022. Strategic assets (PP&E of Rs16.79 Billion plus long-term investments of Rs-) total Rs16.79 Billion, measured against net assets of Rs76.51 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Gland Pharma Limited balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Gland Pharma Limited Strategic Asset Allocation Index (2017–2022)
This chart shows how Gland Pharma Limited's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of September 2022, the index stands at 21.9%, representing strategic assets of Rs16.79 Billion against net assets of Rs76.51 Billion INR. For live market cap and overall valuation, see GLAND company net worth.
Annual Strategic Asset Allocation Index for Gland Pharma Limited (2017–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Gland Pharma Limited from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Gland Pharma Limited (GLAND) shareholders funds for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 23.5% | Rs16.80 Billion | Rs16.80 Billion | Rs- | Rs71.58 Billion | ▲ +1.6 pp |
| 2021 | 21.9% | Rs12.92 Billion | Rs12.92 Billion | Rs- | Rs59.03 Billion | ▼ -9.8 pp |
| 2020 | 31.7% | Rs11.57 Billion | Rs11.57 Billion | Rs- | Rs36.46 Billion | ▼ -5.1 pp |
| 2019 | 36.8% | Rs10.53 Billion | Rs10.53 Billion | Rs- | Rs28.62 Billion | ▼ -6.5 pp |
| 2018 | 43.3% | Rs10.43 Billion | Rs10.43 Billion | Rs- | Rs24.10 Billion | ▼ -6.2 pp |
| 2017 | 49.4% | Rs10.33 Billion | Rs10.33 Billion | Rs- | Rs20.90 Billion | — |